Shattuck Labs Inc - STTK Book Capitalization
The available price movement vector for Shattuck Labs, Inc. (STTK) on GURU.Markets is currently at 0.21. Shattuck Labs, Inc. (STTK) develops immunotherapy via the ARC system, with expectations for SL-172154 to succeed in combating leukemia. The business model relies on external protein synthesis, providing financial leverage upon FDA approval. Project success depends on the outcomes of oncology drug trials, while market capitalization remains stable.
%20Company%20Book%20Value&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_STTK_-_Shattuck-Labs-Inc._-_Company-Book-Value "Shattuck Therapeutics (STTK): Net Asset Value from 07/04/2022 to 10/28/2026 | 👁️GURU.Markets👁️")
Metric breakdowns and analytics for Shattuck Therapeutics (STTK)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental valuation:STTK - Shattuck Labs
Book value capitalization reflects the net value of the business, representing the difference between all assets and the total liabilities of the company. By analyzing the total book capitalization, an investor assesses the actual amount of equity in Shattuck Labs, Inc. (STTK), which is critical given the high burn rate for protein clinical trials and the risk of share dilution during new issuances.
Competitor analysis for Shattuck Labs, Inc.
ARGX: Total Net Assets|BNTX: Company Book Value|ABVX (ABIVAX) - Book Capitalization|Company Book Value ADMA Biologics, Inc. ADMA|Net Asset Value Protagonist Therapeutics, Inc.|Immunovant Corp (IMVT) - Book Capitalization|Accounting Value of Company Kiniksa Corp (KNSA)|Book Capitalization GRFS (Grifols, S.A.)|adaptivebiotech.com - Book Capitalization|Company Book Value Celldex Therapeutics, Inc. (CLDX)|AUPH: Accounting Value of Company|BCRX (BioCryst Pharmaceuticals Inc) - Company Book Value|Vera Corp (VERA) - Company Net Assets|DNTH (Dianthus Therapeutics) - Book Capitalization|Book Capitalization pharvaris.com (PHVS)|AbCellera Bio (ABCL) - Company Net Assets|Accounting Value of Company Tourmaline Bio Inc (TRML)|Book Capitalization PGEN|Pharming Corp - Book Valuation of Business|NKTR: Company Book Value|UPB: Company Net Assets|ZBIO (Zenas Biopharma) - Company Book Value|Company Net Assets Immunome Inc|GOSS (Gossamer Corp) - Company Net Assets|Book Capitalization KALV|Company Book Value Septerna Inc SEPN|Accounting Capitalization pieris.com (PVLA)|SVRA: Book Capitalization|Rigel Pharma - Total Stockholders' Equity|Company Book Value ANAB (AnaptysBio Corp)|ATXS - Book Valuation of Business|Book Capitalization enGene Holdings Inc. ENGN|rapt.com (RAPT) - Accounting Value of Company|JBIO (Aerovate Therapeutics, Inc.) - Book Capitalization|Book Capitalization Aclaris Therapeutics Inc. (ACRS)|Company Net Assets Kyverna|Total Net Assets Tiziana Life Sciences, Ltd. TLSA|Company Net Assets Cabaletta Bio, Inc. (CABA)|VTYX - Total Net Assets|Theratechnologies - Company Net Assets|AVTX - Book Capitalization|ELDN (Eledon) - Book Capitalization|AGEN (Agenus, Inc) - Company Net Assets|CLYM (Climb Bio Inc) - Company Book Value|Book Capitalization zurabio.com (ZURA)|aTyr Pharma (ATYR) - Company Net Assets|Accounting Value of Company ADAG (adagene.com)|Company Book Value Ikena Oncology IMA|Company Book Value Equillium Inc EQ|Connect Pharma - Book Capitalization|IMUX - Book Capitalization|atarabio.com (ATRA) - Book Capitalization|IFRX (InflaRx) - Company Book Value|XFOR: Company Book Value|Book Valuation of Business Adicet (ACET)|Celularity Inc. (CELU) - Company Net Assets|Accounting Value of Company inmunebio.com (INMB)|Book Capitalization BRNS|Kezar Life Sciences Inc. - Book Valuation of Business|SAB Biotherapeutics, Inc (SABS) - Company Book Value|AKTX - Accounting Capitalization|ENLV (enlivex.com) - Book Capitalization|Company Net Assets Q32 Bio|GOVX: Company Net Assets|Book Valuation of Business EDSA|IBIO (iBio Corp) - Company Book Value|Book Valuation of Business carismatx.com CARM|Company Net Assets XTL Biopharmaceuticals (XTLB)|BOLT - Total Net Assets|Company Net Assets HCW Biologics Inc HCWB|APVO: Total Net Assets|AIM: Company Book Value|ADTX (Aditxt, Inc.) - Book Capitalization|Company Book Value GRI Bio, Inc. GRI|Net Asset Value xortx.com|Vyome Holdings (HIND) - Book Capitalization|Accounting Value of Company Revelation Biosciences Inc (REVB)|Book Capitalization INDP (Indaptus)|BiondVax Pharmaceuticals - Book Capitalization|Company Book Value CalciMedica Corp (CALI)|AFMD: Accounting Value of Company|ALLK (allakos.com) - Company Book Value|HOOKIPA Pharma (HOOK) - Company Net Assets|IGMS (IGM Biosciences Inc.) - Book Capitalization|Book Capitalization iTeos Pharma (ITOS)|Ocean Biomedical, Inc. (OCEA) - Company Net Assets|Accounting Value of Company tcbiopharm.com (TCBP)|Book Capitalization THRD